Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Preliminary Efficacy of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Pediatric and Young Adult Participants With Solid Tumors

Hoffmann-La Roche · 2015
ClinicalTrials.gov · Datasets · License: Public Domain · 2015
Open Source ↗
solid tumor, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 806920
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.